AU3557889A - Protective peptides derived from human immunodeficiency virus-1 gp160 - Google Patents

Protective peptides derived from human immunodeficiency virus-1 gp160

Info

Publication number
AU3557889A
AU3557889A AU35578/89A AU3557889A AU3557889A AU 3557889 A AU3557889 A AU 3557889A AU 35578/89 A AU35578/89 A AU 35578/89A AU 3557889 A AU3557889 A AU 3557889A AU 3557889 A AU3557889 A AU 3557889A
Authority
AU
Australia
Prior art keywords
immunodeficiency virus
human immunodeficiency
peptides derived
protective peptides
protective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35578/89A
Inventor
Mark I. Greene
David B. Weiner
William V. Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania Penn filed Critical University of Pennsylvania Penn
Publication of AU3557889A publication Critical patent/AU3557889A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU35578/89A 1988-04-20 1989-04-18 Protective peptides derived from human immunodeficiency virus-1 gp160 Abandoned AU3557889A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18384088A 1988-04-20 1988-04-20
US183840 1988-04-20

Publications (1)

Publication Number Publication Date
AU3557889A true AU3557889A (en) 1989-11-24

Family

ID=22674513

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35578/89A Abandoned AU3557889A (en) 1988-04-20 1989-04-18 Protective peptides derived from human immunodeficiency virus-1 gp160

Country Status (7)

Country Link
KR (1) KR900700626A (en)
AU (1) AU3557889A (en)
CA (1) CA1341391C (en)
IE (1) IE61966B1 (en)
PT (1) PT90329B (en)
WO (1) WO1989010416A1 (en)
ZA (1) ZA892907B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU650911B2 (en) * 1990-09-27 1994-07-07 Syntello Vaccine Development Kb Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346989A (en) * 1990-08-22 1994-09-13 Syntello Vaccine Development Kb Peptides for use in induction of T cell activation against HIV-1
US5840313A (en) * 1990-09-27 1998-11-24 Syntello Vaccine Development Kb Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
EP0594638A1 (en) * 1991-06-03 1994-05-04 Syntello Vaccine Development Ab Peptides for use in induction of t cell activation against hiv-1
FR2677364A1 (en) * 1991-06-05 1992-12-11 Pasteur Institut Peptide sequences of the external HIV-1 retrovirus envelope glycoprotein
GB9208428D0 (en) * 1992-04-16 1992-06-03 Proteus Molecular Design Synthetic polypeptides
DE4405810A1 (en) 1994-02-23 1995-08-24 Behringwerke Ag Peptides derived from a retrovirus from the HIV group and their use
GB2313376A (en) * 1996-05-22 1997-11-26 Diapharm Limited Polypeptide immunologically cross-reactive with NTM peptide and with vasoactive intestinal peptide (VIP)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743678A (en) * 1983-04-27 1988-05-10 President And Fellows Of Harvard College Method and products for detection of human T cell leukemia virus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU650911B2 (en) * 1990-09-27 1994-07-07 Syntello Vaccine Development Kb Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus

Also Published As

Publication number Publication date
IE61966B1 (en) 1994-11-30
WO1989010416A1 (en) 1989-11-02
PT90329A (en) 1989-11-10
PT90329B (en) 1994-09-30
KR900700626A (en) 1990-08-16
IE891260L (en) 1989-10-20
ZA892907B (en) 1990-03-28
CA1341391C (en) 2002-10-01

Similar Documents

Publication Publication Date Title
AU5726694A (en) Human immunodeficiency virus decoy
AU2383188A (en) Bradykinin antagonist peptides
AU4325089A (en) Viral vaccines
LTIP335A (en) Vaccine for human immunodeficiency virus
EP0853662A4 (en) Novel replication competent human immunodeficiency virus type 2 (hiv-2) proviral clone designated hiv-2kr
AU7252291A (en) Inhibition of human immunodeficiency virus -1 infectivity in human cells
AU3414689A (en) Therapeutic peptides
AU4954596A (en) Recombinant human immunodeficiency virus-producing cell
AU3526689A (en) Peptides that block the binding of hiv-1 to the cd4 receptor protein
AU3977589A (en) Novel peptides
AU5449590A (en) Anti-hiv drug
AU7851687A (en) Anti-inflammatory peptides
AU3557889A (en) Protective peptides derived from human immunodeficiency virus-1 gp160
AU5848794A (en) Multiple-gene mutants of human immunodeficiency virus (hiv) for vaccine use
AU3836489A (en) Treatment of immunodeficiency
AU6161794A (en) Peptides having anti-hiv activity
AU7516494A (en) Oligomers for modulating human immunodeficiency virus
AU6877991A (en) A method of inactivating human immunodeficiency virus
AU2023092A (en) New hiv-1 gag and env peptides, diagnostic
AU3048689A (en) Immunogenic peptides
AU1676288A (en) Human immunodeficiency virus gag-encoded proteins
AU4664689A (en) Proteolytic fragments obtained from human cytomegalovirus glycoprotein complex i
AU7263994A (en) Novel mutated human and simian immunodeficiency viruses and vaccines containing said viruses
AU4576789A (en) Synthetic peptide derivatives of gp41 glycoprotein of HIV
AU5117590A (en) SDK peptides, a preparation process of the same and therapeutic compositions containing them